Search

everythinglearnresearchcommunity

for

Search:↓

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Finasteride treats hair loss but may affect prostate cancer detection.

Higher PSA levels are linked to more hirsutism in women with PCOS.

PSA can help diagnose high androgen levels in women.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Suppressing certain hormones might help prevent prostate cancer.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Micrografts improve hair density and thickness without side effects.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A new compound was effective for imaging prostate cancer in rats.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.